High School of Physical Education and Sport, University of Bingöl, 12000, Bingöl, Turkey.
Faculty of Veterinary Medicine, Department of Biochemistry, University of Erciyes, Melikgazi, 38039, Kayseri, Turkey.
Biol Trace Elem Res. 2018 Jul;184(1):165-172. doi: 10.1007/s12011-017-1182-0. Epub 2017 Oct 10.
In this study, we evaluated the effect of boron (B) as boric acid (BA) on body weight (b.w.); blood glucose; plasma insulin; lipase and paraoxonase (PON1) activities; and serum triglyceride, total cholesterol, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, lipid peroxidation (MDA), and total antioxidant capacity (TAC) in streptozotocin (STZ)-induced experimental diabetes in rats. Sixty Wistar albino rats (200-250 g) were divided into six groups of ten. The groups received the following treatment: group 1, control group; group 2, 50 mg/kg (b.w.) i.p. STZ-induced diabetes; group 3, 5 mg/kg (b.w.) B; group 4, 10 mg/kg (b.w.) B; group 5, diabetes + 5 mg/kg (b.w.) B; and group 6, diabetes + 10 mg/kg (b.w.) B. The experiment lasted 4 weeks. Increased serum MDA levels with diabetes were significantly reduced and although it is not statistically significant, serum TAC levels approached to values of control group; also, insignificant increases were observed in HDL cholesterol levels in experimental diabetic rats with treatment 5 and 10 mg/kg B. Furthermore, body weight, plasma insulin, and lipase activities increased insignificantly, blood glucose and serum LDL cholesterol decreased significantly, and total cholesterol levels decreased insignificantly in the diabetes + 10 mg/kg B group. There was no difference between the groups in terms of plasma PON1 activities and serum triglyceride levels. In conclusion, B may have beneficial effects on some biochemical parameters changes in experimental diabetes, and in order to determine the full effect of this element on the metabolism, further studies are required which use various dosages and compounds of B.
在这项研究中,我们评估了硼(B)作为硼酸(BA)对体重(b.w.)、血糖、血浆胰岛素、脂肪酶和对氧磷酶 1(PON1)活性以及血清甘油三酯、总胆固醇、高密度脂蛋白(HDL)和低密度脂蛋白(LDL)胆固醇、脂质过氧化(MDA)和总抗氧化能力(TAC)的影响,这些指标均在链脲佐菌素(STZ)诱导的实验性糖尿病大鼠中进行评估。60 只 Wistar 白化大鼠(200-250g)分为 10 组,每组 10 只。这些组接受了以下治疗:第 1 组,对照组;第 2 组,50mg/kg(b.w.)腹腔注射 STZ 诱导的糖尿病;第 3 组,5mg/kg(b.w.)B;第 4 组,10mg/kg(b.w.)B;第 5 组,糖尿病+5mg/kg(b.w.)B;第 6 组,糖尿病+10mg/kg(b.w.)B。实验持续了 4 周。糖尿病大鼠血清 MDA 水平升高,经治疗后显著降低,尽管统计学上无显著差异,但血清 TAC 水平接近对照组;同时,治疗组 5 和 10mg/kg B 使实验性糖尿病大鼠的 HDL 胆固醇水平略有升高。此外,糖尿病+10mg/kg B 组大鼠的体重、血浆胰岛素和脂肪酶活性略有增加,血糖和血清 LDL 胆固醇显著降低,总胆固醇水平略有降低。各组之间的血浆 PON1 活性和血清甘油三酯水平无差异。总之,B 可能对实验性糖尿病的一些生化参数变化具有有益的影响,为了确定该元素对代谢的全面影响,需要进一步研究使用各种剂量和 B 的化合物。